Phospholemman modulates the gating of cardiac L-type calcium channels

Biophysical Journal

Volumn 98, Issue 7, 2010, Pages 1149-1159

  Wang, Xianming ^a   Gao, Guofeng ^a   Guo, Kai ^a,b   Yarotskyy, Viktor ^a   Huang, Congxin ^b   Elmslie, Keith S ^a   Peterson, Blaise Z ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAVIA;

CALCIUM; CALCIUM CHANNEL L TYPE; ION; MEMBRANE PROTEIN; PHOSPHOLEMMAN; PHOSPHOPROTEIN;

ACTION POTENTIAL; ANIMAL; BIOLOGICAL MODEL; GUINEA PIG; HEART; HEART VENTRICLE; HUMAN; ISCHEMIA; METABOLISM; MUSCLE CELL; PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TACHYCARDIA;

ACTION POTENTIALS; ANIMALS; CALCIUM; CALCIUM CHANNELS, L-TYPE; GUINEA PIGS; HEART; HEART VENTRICLES; HUMANS; IONS; ISCHEMIA; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MUSCLE CELLS; PHOSPHOPROTEINS; PROTEIN STRUCTURE, TERTIARY; TACHYCARDIA;

EID: 77950660038     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.11.032     Document Type: Article

References (51)

1. HiIIe, B. 2001. Ion Channels of Excitable Membranes. Sinauer, Sunderland, MA.
2. Splawski, I., K. W. Timothy, ..., M. T. Keating. 2004. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 119:19-31. (Pubitemid 39349317)
3. Barrett, C. F., and R. W. Tsien. 2008. The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV.1.2 L-type calcium channels. Proc. Natl. Acad. Sci. USA, 105: 2157-2162.
4. Yarotskyy, V., G. Gao, ..., K. S. Elmslie. 2009. The Timothy syndrome mutation of cardiac CaV 1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation. J. Physiol. 587:551-565.
5. Buraei, Z., M. Anghelescu, and K. S. Elmslie. 2005. Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine. Biophys. J. 89:1681-1691. (Pubitemid 41233525)
6. Fuller, W., P. Eaton, ..., M. J. Shattock. 2004. Ischemia-induced phosphorylation of phospholemman directly activates rat cardiac Na/KATPase. FASEB J. 18:197-199.
7. i transients in adult rat cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 286: H1322-H1330.
8. Catterall, W. A., J. T. Hulme, ..., W. P. Few. 2006. Regulation of sodium and calcium channels by signaling complexes. J. Recept. Signal Transduct. Res. 26:577-598. (Pubitemid 44849906)
9. Hockerman, G. H., B. D. Johnson, ..., W. A. Catterall. 1997. Molecular determinants of high affinity phenylalkylamine block of L-type calcium, channels in transmembrane segment IIIS6 and the pore region of the alphal subunit. J. Biol. Chem. 272:18759-18765.
10. Elmslie, K. S. 2004. Calcium channel blockers in the treatment of disease. J. Neurosci. Res. 75:733-741. (Pubitemid 38296086)
11. McDonald, T. F., S. Pelzer, ..., D. J. Pelzer. 1994. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol. Rev. 74:365-507. (Pubitemid 24127646)
12. 2+-dependent inactivation of L-type calcium channels. Neuron. 22:549-558.
13. Sweadner, K. J., and E. Rael. 2000. The FXYD gene family of small ion. transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics. 68:41-56.
14. Geering, K. 2006. FXYD proteins: new regulators of Na-K-ATPase. Am. J. Physiol. Renal Physiol. 290:F241-F250. (Pubitemid 43724978)
15. Crambert, G., M. Fuzesi, ..., K. Geering. 2002. Phospholemman (FXYDl.) associates with Na, K-ATPase and regulates its transport properties. Proc. Natl. Acad. Sci. USA, 99:11476-11481. (Pubitemid 34920950)
16. Despa, S., J. Bossuyt, ..., D. M. Bers. 2005. Phospholemman- phosphorylation mediates the beta-adrenergic effects on Na/K pump function in cardiac myocytes. Circ. Res. 97:252-259. (Pubitemid 41105451)
17. Garty, H., and S. J. Karlish. 2006. Role of FXYD proteins in ion transport. Annu. Rev. Physiol. 68:431-459.
18. 2+ exchange in adult rat cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 284:H225-H233.
19. + exchanger, phospholemman. J. Biol. Chem. 280:19875-19882.
20. Cheung, J. Y. 2008. Regulation of cardiac contractility: high time for FXYD. Am. J. Physiol. Heart Circ. Physiol. 294:H584-H585.
21. Jin, Q., W. Ding, and K. M. Mulder. 2007. Requirement for the dynein light chain km23-l in a Smad2-dependent transforming growth, factorbeta signaling pathway. J. Biol. Chem. 282:19122-19132. (Pubitemid 47100189)
22. Wang, X., T. A. Ponoran, ..., B. Z. Peterson. 2005. Amino acid substitutions in the pore of the Ca(V)1.2 calcium channel reduce barium currents without affecting calcium currents. Biophys. J. 89:1731-1743. (Pubitemid 41233530)
23. 2+ channels. J. Biol., Chem., 266:21943-21947.
24. Tomlinson, W. J., A. Stea, ...., T. P. Snutch. 1993. Functional properties of a neuronal class C L-type calcium channel. Neuropharmacology. 32:1117-1126. (Pubitemid 23322108)
25. Perez-Reyes, E., A. Castellano, ..., L. Birnbaumer. 1992. Cloning and expression, of a cardiac/brain beta subunit of the L-type calcium channel. J. Biol. Chem. 267:1792-1797.
26. 2+ exchanger by phospholemman. Ann. N. Y. Acad. Sci. 1099:119-134.
27. Zühlke, R. D., G. S. Pitt.....H. Reuter. 1999. Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature. 399:159-162. (Pubitemid 129524348)
28. 2+/ calmodulin binds to and modulates P/Q-type calcium channels. Nature. 399:155-159.
29. 2+ channel depends on calmodulin. Proc. Natl. Acad. Sci. USA. 96:2435-2438.
30. Elmslie, K. S., and S. W. Jones. 1994. Concentration, dependence of neurotransmitter effects on calcium current kinetics in frog sympathetic neurones. J. Physiol. 481:35-46.
31. Hess, P., J. B. Lansman, and R. W. Tsien. 1984. Different modes of Ca channel gating behavior favored by dihydropyridine Ca agonists and antagonists. Nature. 311:538-544. (Pubitemid 14046377)
32. Pietrobon, D., and P. Hess. 1990. Novel mechanism of voltage-dependent gating in L-type calcium channels. Nature. 346:651-655. (Pubitemid 20266396)
33. Yarotskyy, V., and K. S. Elmslie. 2007. Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (Ca(V)1.2) calcium channels. Br. J. Pharmacol. 152:386-395. (Pubitemid 47511263)
34. Splawski, I., K. W. Timothy, ..., M. T. Keating. 2005. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl, Acad. Sci. USA. 102:8089-8096, discussion 8086-8088. (Pubitemid 40800048)
35. Reference deleted in proof.
36. Sicouri, S., K. W. Timothy,..., C. Antzelevitch. 2007. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine. Heart Rhythm. 4:638-647. (Pubitemid 46630371)
37. 2+ channel and its role in myocyte electrophysiology : a theoretical investigation. Biophys. J. 92:1522-1543.
38. 2+ channel mutations and T-wave alternans: a model study. Am. J. Physiol. Heart Circ. Physiol. 293:H3480-H3489.
39. 2+ channel currents in guinea-pig ventricular myocytes. J. Physiol. 541:741-751.
40. Nowycky, M. C., A. P. Fox, and R. W. Tsien. 1985. Long-opening mode of gating of neuronal calcium channels and its promotion by the dihydropyridine calcium agonist Bay K 8644. Proc. Natl. Acad. Sci. USA. 82:2178-2182.
41. Tsien, R. W., B. P. Bean, ..., M. C. Nowycky. 1986. Mechanisms of calcium channel modulation by beta-adrenergic agents and dihydropyridine calcium agonists. J. Mol. Cell. Cardiol. 18:691-710. (Pubitemid 16056683)
42. Wilkens, C. M., M. Grabner, and K. G. Beam. 2001. Potentiation of the cardiac L-type Ca(2+) channel (alpha(1C)) by dihydropyridine agonist and strong depolarization occur via distinct mechanisms. J. Gen. Physiol. 118:495-508.
43. Marks, T. N., and S. W. Jones. 1992. Calcium currents in the A7r5 smooth, muscle-derived cell line. An allosteric model for calcium channel activation and dihydropyridine agonist action. J. Gen. Physiol. 99:367-390.
44. Jia, L. G., C. Donnet, ..., A. L. Tucker. 2005. Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 288:H1982-H1988.
45. Bell, J. R., E. Kennington,..., M. J. Shattock. 2008. Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity. Am. J. Physiol. Heart Circ. Physiol. 294:H613-H621.
46. Reference deleted in proof.
47. Bossuyt, J., X. Ai, ..., D. M. Bers. 2005. Expression and phosphorylation of the Na-pump regulatory subunit phospholemman in heart failure. Circ. Res. 97:558-565. (Pubitemid 41361746)
48. Song, J., X. Q. Zhang,..., J. Y. Cheung. 2002. Overexpression of phospholemman alters contractility and [Ca(2+)](i) transients in adult rat myocytes. Am. J. Physiol. Heart Circ. Physiol. 283:H576-H583. (Pubitemid 34790851)
49. +-ATPaSe. Am. J. Physiol. Heart Circ. Physiol. 295:H1615-H1625.
50. 2+ exchange. Am. J. Physiol. Heart Circ. Physiol. 291:H2199-H2209.
51. Erxleben, C, Y. Liao, ..., D. L. Armstrong. 2006. Cyclosporin and Timothy syndrome increase mode 2 gating of CaV1.2 calcium channels through aberrant phosphorylation of S6 helices. Proc. Natl. Acad. Sci. USA. 103:3932-3937. (Pubitemid 43376658)